GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYES) » Definitions » Institutional Ownership

Second Sight Medical Products (Second Sight Medical Products) Institutional Ownership : 5.63% (As of May. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Second Sight Medical Products Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Second Sight Medical Products's institutional ownership is 5.63%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Second Sight Medical Products's Insider Ownership is 1.55%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Second Sight Medical Products's Float Percentage Of Total Shares Outstanding is 71.26%.


Second Sight Medical Products Institutional Ownership Historical Data

The historical data trend for Second Sight Medical Products's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Institutional Ownership Chart

Second Sight Medical Products Historical Data

The historical data trend for Second Sight Medical Products can be seen below:

2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31
Institutional Ownership 6.06 6.14 6.19 6.19 6.26 6.27 6.29 6.29 5.63 5.63

Second Sight Medical Products Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Second Sight Medical Products (Second Sight Medical Products) Business Description

Traded in Other Exchanges
N/A
Address
13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Executives
Lisa Ellen Porter officer: Chief Medical Officer 778 CORDILLERAS AVE, SAN CARLOS CA 94070
Donald Dwyer officer: Chief Business Officer 54 CHERRY FARM LANE, WEST CHESTER PA 19382
Truc Le officer: COO 1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn director, officer: CEO C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Brigid Makes officer: CFO 20245 SW 95TH AVENUE, TUALATIN OR 97062
Gregg Williams director, 10 percent owner PO BOX 200, WALLED LAKE MI 48390-0200
Wilford Dean Baker director 200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p. director 3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar officer: Acting CEO 13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo officer: Controller 4485 FORESTGLEN CT, MOORPARK CA 93021
Jonathan Will Mcguire director, officer: Chief Executive Officer 96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Jessy Dana Dorn officer: VP-Clin & Scientific Affairs 12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Edward David Randolph officer: Vice President Manufacturing 12744 SAN FERNANDO ROAD, BLDG. 3, SYLMAR CA 91342
Matthew J Pfeffer director
Aaron Mendelsohn director 224 15TH STREET, SANTA MONICA CA 90402